Intas Pharmaceuticals Overview
- Year Founded
-
1976
- Status
-
Private
- Employees
-
19,000
- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
13
- Investments
-
3
Intas Pharmaceuticals General Information
Description
Operator of a global pharmaceutical company intended to offer biopharmaceutical products and services. The company specializes in oncology products for solid tumors, hematological malignancies and supportive therapies and also offers products for critical disorders. Its success and incessant growth lie in the clinical execution of successful and strategic moves made in the areas of manufacturing, R&D, Biotechnology and global operations over three decades.
Contact Information
Website
www.intaspharma.comCorporate Office
- Corporate House, Near Sola Bridge
- S. G. Highway, Thaltej
- Ahmedabad, Gujarat 380054
- India
Corporate Office
- Corporate House, Near Sola Bridge
- S. G. Highway, Thaltej
- Ahmedabad, Gujarat 380054
- India
Intas Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Intas Pharmaceuticals Comparisons
Industry
Financing
Details
Intas Pharmaceuticals Competitors (44)
One of Intas Pharmaceuticals’s 44 competitors is Biocon, a Formerly PE-Backed company based in Bengaluru, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Biocon | Formerly PE-Backed | Bengaluru, India | ||||
| Merck & Co. | Corporation | Rahway, NJ | ||||
| Glenmark Pharmaceuticals | Corporation | Mumbai, India | ||||
| Coherus Biosciences | Formerly VC-backed | Redwood City, CA | ||||
| Ajanta Pharma | Corporation | Mumbai, India |
Intas Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Intas Pharmaceuticals Patents
Intas Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023337007-A1 | Upadacitinib formulation | Pending | 09-Sep-2022 | ||
| EP-4504207-A1 | An orodispersible tablet of rivaroxaban | Pending | 08-Apr-2022 | ||
| EP-4504748-A1 | Multi-component buffer system for purification of antibodies | Pending | 04-Apr-2022 | ||
| US-20230181595-A1 | Stable extended release pharmaceutical composition of clozapine | Active | 15-Dec-2021 | ||
| US-11648207-B1 | Extended release pharmaceutical composition of clozapine | Active | 15-Dec-2021 | A61K31/5513 |
Intas Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Intas Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Intas Pharmaceuticals Investments (3)
Intas Pharmaceuticals’s most recent deal was a Buyout/LBO with Udenyca for . The deal was made on 11-Apr-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Udenyca | 11-Apr-2025 | Buyout/LBO | Buildings and Property | ||
| RPG Life Sciences (Biotech Unit) | 04-Oct-2016 | Buyout/LBO | Biotechnology | ||
| Biologics Process Development | 19-Jun-2008 | Buyout/LBO | Laboratory Services (Healthcare) |
Intas Pharmaceuticals Exits (1)
Intas Pharmaceuticals’s most recent exit was on 19-Jun-2008 from Biologics Process Development. The exit was categorized as with 3 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Biologics Process Development | 19-Jun-2008 | Completed |
|
Intas Pharmaceuticals FAQs
-
When was Intas Pharmaceuticals founded?
Intas Pharmaceuticals was founded in 1976.
-
Where is Intas Pharmaceuticals headquartered?
Intas Pharmaceuticals is headquartered in Ahmedabad, India.
-
What is the size of Intas Pharmaceuticals?
Intas Pharmaceuticals has 19,000 total employees.
-
What industry is Intas Pharmaceuticals in?
Intas Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Intas Pharmaceuticals a private or public company?
Intas Pharmaceuticals is a Private company.
-
What is the current valuation of Intas Pharmaceuticals?
The current valuation of Intas Pharmaceuticals is .
-
What is Intas Pharmaceuticals’s current revenue?
The current revenue for Intas Pharmaceuticals is .
-
How much funding has Intas Pharmaceuticals raised over time?
Intas Pharmaceuticals has raised $201M.
-
Who are Intas Pharmaceuticals’s investors?
Abu Dhabi Investment Authority, Temasek Holdings, and ChrysCapital have invested in Intas Pharmaceuticals.
-
Who are Intas Pharmaceuticals’s competitors?
Biocon, Merck & Co., Glenmark Pharmaceuticals, Coherus Biosciences, and Ajanta Pharma are some of the 44 competitors of Intas Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
